Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Since the number of cases in TCGA-BRCA was much higher than TCGA-UVM, we obtained highly correlated genes with BAP1 in invasive breast carcinomas.
|
30716094 |
2019 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Common mutations that promote uveal melanoma initiation and progression include alterations in G protein subunit alpha q/11 (GNAQ/GNA11) and breast cancer gene 1-associated protein 1 (BAP1).
|
29206651 |
2018 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Taken together, our findings provide the first clues regarding the role of miR-125a-5p as a tumour suppressor in BC via the inhibition of BAP1 translation.
|
30076753 |
2018 |
Breast Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations of the oncosuppressor gene breast cancer 1-associated protein 1 (BAP1) were recently related to an autosomal-dominant tumor predisposition syndrome (BAP1-TPDS), characterized by uveal melanoma, malignant mesothelioma (MM), cutaneous melanoma, and other malignancies.
|
28551647 |
2017 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
We have recently shown that the breast cancer (BRCA)1-associated protein-1 tumor suppressor gene (BAP1) is inactivated in a subset of clinically aggressive meningiomas that display rhabdoid histomorphology.
|
28482042 |
2017 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Normal nuclear staining for breast cancer 1 gene (BRCA1)-associated protein 1 suggested that the tumor was likely of disomy 3 type with a favorable prognosis.
|
28159633 |
2017 |
Breast Carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
To define genomic aberrations of rhabdoid meningiomas, we performed sequencing of cancer-related genes in 27 meningiomas from 18 patients with rhabdoid features and evaluated breast cancer [BRCA]1-associated protein 1 (BAP1) expression by immunohistochemistry in 336 meningiomas.
|
28170043 |
2017 |
Breast Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The recent technological advances have allowed the identification of new genes involved in melanoma susceptibility: breast cancer 1 (BRCA1), BRCA1-associated protein 1 (BAP1), and telomerase reverse transcriptase (TERT).Tests on these genes allow to identify a larger number of high-risk individuals with a potential of developing familial melanoma and primary multiple melanomas.
|
28121081 |
2017 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
|
26719535 |
2016 |
Breast Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
One of these patients presented with an invasive breast cancer with the tumor tissue showing partial loss of the mutant rather than the wild type allele, suggesting that the germline BAP1 mutation didn't contribute to breast cancer development in this patient.
|
26748926 |
2016 |
Breast Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We used a custom-made comparative genomic hybridization array (aCGH; average probe interval 254 bp) to screen 33 malignant mesothelioma (MM) biopsies for somatic copy number loss throughout the 3p21 region (10.7 Mb) that harbors 251 genes, including BRCA1 (breast cancer 1)-associated protein 1 (BAP1), the most commonly mutated gene in MM.
|
27834213 |
2016 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Breast cancer 1-associated protein 1 (BAP1) is a nuclear deubiquitinase that regulates gene expression, transcription, DNA repair, and more.
|
25658628 |
2015 |
Breast Carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Collectively, our findings not only identify BAP1 as the DUB for KLF5, but also reveal a critical mechanism that regulates KLF5 expression in breast cancer.
|
26419610 |
2015 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
CTD_human |
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
|
25231345 |
2015 |
Breast Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
BAP1 mutations contribute to a high frequency of tumors with breast cancer (BRCA) DNA repair pathway alterations and were significantly associated with papillary histologic features in tumors.
|
25225064 |
2014 |
Breast Carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
|
23664488 |
2013 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.
|
19197335 |
2009 |
Breast Carcinoma
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
|
18949367 |
2008 |
Breast Carcinoma
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The lack of detection of deleterious mutations suggests that BAP1 is not a high risk breast cancer predisposing gene.
|
16341802 |
2005 |
Breast Carcinoma
|
0.600 |
Biomarker
|
disease |
BEFREE |
BAP1 enhances BRCA1-mediated inhibition of breast cancer cell growth and is the first nuclear-localized ubiquitin carboxy-terminal hydrolase to be identified.
|
9528852 |
1998 |
Breast Carcinoma
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|